THE EFFECT ON SERUM-LIPID CONCENTRATIONS OF A PROLONGED INFUSION OF PROPOFOL - HYPERTRIGLYCERIDEMIA ASSOCIATED WITH PROPOFOL ADMINISTRATION

被引:55
作者
EDDLESTON, JM [1 ]
SHELLY, MP [1 ]
机构
[1] WITHINGTON HOSP,INTENS CARE UNIT,MANCHESTER M20 8LR,LANCS,ENGLAND
关键词
PROPOFOL; HYPERTRIGLYCERIDEMIA; CRITICAL CARE;
D O I
10.1007/BF01720682
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Serum concentrations of triglyceride, cholesterol and high density lipoprotein-cholesterol (HDL-cholesterol) were measured in an ICU patient after he had received a 10-day continuous infusion of propofol. No additional parenteral lipid was given in the 72 h prior to initial sampling, but a total of 71 of 10% intralipid had been administered over the remaining 7 days. The total cumulative dose of propofol was 66.1 g (range 0.7- 6.4 mg kg-1 h-1). There was no visual appearance of lipaemia. Both the serum triglyceride and cholesterol concentrations increased (triglyceride level increased to 4 times normal whereas the cholesterol elevation was minimal). The HDL-cholesterol concentration decreased. At 72 h after discontinuing the infusion of propofol the triglyceride level remained elevated, the cholesterol concentration had returned to normal and the HDL-cholesterol concentration remained unchanged. The implications of hypertriglyceridaemia are discussed.
引用
收藏
页码:424 / 426
页数:3
相关论文
共 9 条
[1]
INJURY SEVERITY SCORE - METHOD FOR DESCRIBING PATIENTS WITH MULTIPLE INJURIES AND EVALUATING EMERGENCY CARE [J].
BAKER, SP ;
ONEILL, B ;
HADDON, W ;
LONG, WB .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1974, 14 (03) :187-196
[2]
[3]
DURRINGTON PN, 1984, BR J HOSP MED, P28
[4]
EFFECT OF PROLONGED SEDATION WITH PROPOFOL ON SERUM TRIGLYCERIDE AND CHOLESTEROL CONCENTRATIONS [J].
GOTTARDIS, M ;
KHUNLBRADY, KS ;
KOLLER, W ;
SIGL, G ;
HACKL, JM .
BRITISH JOURNAL OF ANAESTHESIA, 1989, 62 (04) :393-396
[5]
HEINRICHS W, 1989, Journal of Drug Development, V2, P53
[6]
MERTES N, 1989, Journal of Drug Development, V2, P77
[7]
ROSCHLAN P, 1975, 9TH INT C CLIN CHEM
[8]
SCHAEFER EJ, 1985, NEW ENGL J MED, V312, P1300, DOI 10.1056/NEJM198505163122007
[9]
VINCENT J-L, 1989, Journal of Drug Development, V2, P5